Holen Sie sich die Stockscreener-App
1.39
0.71%
-0.01
Schlusskurs vom Vortag:
$1.40
Offen:
$1.42
24-Stunden-Volumen:
130.06K
Relative Volume:
0.18
Marktkapitalisierung:
$8.07M
Einnahmen:
$3,000
Nettoeinkommen (Verlust:
$-8.79M
KGV:
-0.6609
EPS:
-2.1033
Netto-Cashflow:
$-8.46M
1W Leistung:
+6.11%
1M Leistung:
+2.21%
6M Leistung:
-48.13%
1J Leistung:
-41.84%
1-Tages-Spanne:
$1.35
$1.45
1-Wochen-Bereich:
$1.25
$1.45
52-Wochen-Spanne:
$1.00
$3.20
Biocardia Inc Stock (BCDA) Company Profile
Firmenname
Biocardia Inc
Sektor
Branche
Telefon
650-226-0123
Adresse
320 SOQUEL WAY, SUNNYVALE, CA
Vergleichen Sie BCDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.17 | 4.40B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.96 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
5.05 | 189.47M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.237 | 554.19M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.40 | 0 | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-16 | Herabstufung | Dawson James | Buy → Neutral |
Biocardia Inc Aktie (BCDA) Neueste Nachrichten
How institutional ownership impacts BioCardia Inc. stock2025 AllTime Highs & High Conviction Trade Alerts - newser.com
Using flow based indicators on BioCardia Inc.2025 Market Sentiment & Fast Entry High Yield Tips - newser.com
Custom watchlist performance reports with BioCardia Inc.2025 Major Catalysts & Target Return Focused Picks - newser.com
How BioCardia Inc. (6JU0) stock responds to job market shiftsEarnings Trend Report & Daily Market Momentum Tracking - newser.com
Is BioCardia Inc. forming a bottoming base2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
Can BioCardia Inc. stock sustain institutional interestJuly 2025 Selloffs & Free Real-Time Volume Trigger Notifications - newser.com
What catalysts could drive BioCardia Inc. stock higher2025 Big Picture & Technical Entry and Exit Alerts - newser.com
How strong dollar benefits BioCardia Inc. (6JU0) stockBuy Signal & Verified Swing Trading Watchlists - newser.com
Why BioCardia Inc. stock could benefit from AI revolutionJuly 2025 Gainers & Capital Protection Trading Alerts - newser.com
Can BioCardia Inc. (6JU0) stock sustain free cash flow2025 Volatility Report & AI Powered Trade Plan Recommendations - newser.com
Will BioCardia Inc. (6JU0) stock return to pre crash levelsMarket Weekly Review & Low Drawdown Trading Techniques - newser.com
Price action breakdown for BioCardia Inc.July 2025 Snapshot & High Accuracy Trade Alerts - newser.com
Can BioCardia Inc. stock hit record highs againWeekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com
How to forecast BioCardia Inc. trends using time seriesQuarterly Profit Review & Reliable Price Action Trade Plans - newser.com
Applying sector rotation models to BioCardia Inc.Trade Volume Report & Real-Time Buy Signal Alerts - newser.com
What to expect from BioCardia Inc. in the next 30 daysTrade Performance Summary & Long-Term Capital Growth Strategies - newser.com
Is BioCardia Inc. stock positioned for digital transformationJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - newser.com
BioCardia’s CardiAMP HF II Phase 3 Trial Reaches Milestone With First Patient Enrollment At University Of Wisconsin - Pulse 2.0
Smart tools for monitoring BioCardia Inc.’s price actionQuarterly Trade Report & Safe Entry Momentum Tips - newser.com
Measuring BioCardia Inc.’s beta against major indicesMarket Activity Recap & Daily Technical Forecast Reports - newser.com
What is the fair value estimate for BioCardia Inc. (6JU0) stock in 2025Day Trade & Real-Time Price Movement Reports - newser.com
Why BioCardia Inc. (6JU0) stock appears on watchlistsNew Guidance & Free Real-Time Volume Trigger Notifications - newser.com
BioCardia, Inc. (BCDA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
BioCardia enrolls first patient at UW in phase 3 heart failure trial - Investing.com Canada
BioCardia enrolls first patient at UW in phase 3 heart failure trial By Investing.com - Investing.com South Africa
BioCardia Advances Phase 3 CardiAMP HF II Trial - TipRanks
BioCardia, Inc. Enrolls First Patient in Phase 3 CardiAMP HF II Trial - TradingView
BioCardia Announces University of Wisconsin Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial - The Manila Times
BCDA reports first patient enrollment in Phase 3 CardiAMP HF II - Stock Titan
BioCardia (NASDAQ: BCDA) reports first UW patient enrolled in Phase 3 CardiAMP HF II - Stock Titan
Finanzdaten der Biocardia Inc-Aktie (BCDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Biocardia Inc-Aktie (BCDA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Blank Andrew Scott | Director |
Sep 19 '25 |
Buy |
1.25 |
288,000 |
360,000 |
634,023 |
| Altman Peter | President and CEO |
Sep 19 '25 |
Buy |
1.25 |
48,000 |
60,000 |
216,762 |
| Altman Peter | President and CEO |
Aug 22 '25 |
Buy |
1.83 |
700 |
1,281 |
168,762 |
| Altman Peter | President and CEO |
Aug 13 '25 |
Buy |
1.83 |
100 |
183 |
168,062 |
| Altman Peter | President and CEO |
Aug 12 '25 |
Buy |
1.75 |
400 |
700 |
167,962 |
| Altman Peter | President and CEO |
Aug 11 '25 |
Buy |
1.76 |
1,700 |
2,989 |
167,562 |
| McClung David | Chief Financial Officer |
Jun 30 '25 |
Buy |
2.08 |
4,819 |
9,999 |
47,950 |
| Altman Peter | President and CEO |
Jun 30 '25 |
Buy |
2.08 |
24,096 |
49,999 |
165,862 |
| STERTZER SIMON H | Director |
Jun 30 '25 |
Buy |
2.08 |
72,289 |
150,000 |
192,654 |
| Blank Andrew Scott | Director |
Jun 30 '25 |
Buy |
2.08 |
72,289 |
150,000 |
346,023 |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):